The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals.

The focus of  our research work is on clinical trials and our goals are to prove the effectiveness of BNCT  treatment and to widen the treatments to tumors located in different areas of the body.

We are specially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds.